Recent advances in pelletization technique for oral drug delivery: A review

Current Drug Delivery

Volumn 6, Issue 1, 2009, Pages 122-129

  Rahman, Md Akhlaquer ^a   Ahuja, Alka ^a   Baboota, S ^a   Bhavna, ^a   Bali, Vikas ^a   Saigal, Nitin ^a   Ali, Javed ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Cryopelletization; Extrusion spheronization; Freeze pelletization; Hot melt extrusion; Pelletization

Indexed keywords

2 PROPANOL; ACETIC ACID; ALCOHOL; ETHER; WATER;

CRYOPELLETIZATION; DENSITY; DISSOLUTION; DRUG DELIVERY SYSTEM; DRUG MANUFACTURE; FLOW KINETICS; FREEZE PELLETIZATION; MOISTURE; PARTICLE SIZE; PELLET EXTRUSION; PHYSICAL CHEMISTRY; POROSITY; PRIORITY JOURNAL; REVIEW; SPHERONIZATION; SURFACE PROPERTY; TABLET DISINTEGRATION; TENSILE STRENGTH;

ADMINISTRATION, ORAL; DRUG DELIVERY SYSTEMS; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; TECHNOLOGY, PHARMACEUTICAL;

EID: 61849182093     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720109787048339     Document Type: Review

References (89)

1. Shettigar, R.; Damle, A.V. Controlled release pellets of nitrofurantoin. Ind. J. Pharm. Sci., 1996, 5, 179-85.
2. Gu, L.; Liew, C.V.; Heng, P.W.S. Wet spheronization by rotary processing-a multistage single-pot process for producing spheroids. Drug Dev. Ind. Pharm., 2004, 30, 111-9.
3. Reynolds, A.D. A new technique for the production of spherical particles. Manuf. Chem. Aerosol. News, 1970, 41, 40-6.
4. Sood, A.; Ashokraj, Y.; Panchagnula, R. Multiunit matrix based particulate systems (MUMPS) for controlled delivery of nifedipine. Formulation development using extrusion-spheronization and in vitro evaluation. Pharm. Tech., 2004, 28, 62-71.
5. Bechgaard, H.; Nielsen, G. Controlled Release multiple units and single unit doses. Drug. Dev. Ind. Pharm., 1978, 4, 53-7.
6. Cheboyina, S.; Chambliss, W.G.; Wyandt, C.M. A novel freeze pelletization technique for preparing matrix pellets. Pharm. Tech., 2004, 28, 98-108.
7. Celik, M. In Multiparticulate oral drug delivery, Marcel Dekker.. New York, 1994, pp.181.
8. Tunon, A.; Borjesson, E.; Frenning, G.; Alderborn, G. Drug release from reservoir pellets compacted with some excipients of different physical properties. Eur. J. Pharm. Sci., 2003, 20, 469-77.
9. Santosh, H.; Veiga, F.; Pina, M.; Sousa, J.J. A study on the effect of drying techniques on the mechanical properties of pellets and compacted pellets. Eur. J. Pharm. Sci., 2004, 21, 119-29.
10. Sawicki, W.; Lunio, R. Compressibility of floating pellets with verapamil hydrochloride coated with dispersion Kollicoat SR 30 D. Eur. J. Pharm. Biopharm., 2005, 60, 153-9.
11. Eskilson, C. Controlled release by microencapsulation. Manuf. Chem., 1985, 56, 33-41.
12. Bruce, L.D.; Koleng, J.J.; McGinity, W. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets. Drug. Dev. Ind. Pharm., 2003, 29, 909-14.
13. Kojima, M.; Nakagami, H. Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers. J. Control. Release, 2002, 82, 335-43.
14. Koo, O.M.Y.; Heng, P.W.S. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization. Chem. Pharm. Bull., 2001, 49, 1383-7.
15. Pinto, J.F.; Buckton, G.; Newton, J.M. The influence of four processing and formulation factors on the production of spheres by extrusion spheronization. Int. J. Pharm., 1992, 83, 187-96.
16. Tapia, C.; Buckton, G.; Newton, J.M. Factors influencing the mechanism of release from sustained release matrix pellets produced by extrusion/ spheronization. Int. J. Pharm., 1993, 92, 211-8.
17. Mezreb, N; Charrueau, C; Boy, P; Allain, P; Chaumeil, J.C. Production of Carbopol 974P and Carbopol 971P pellets by extrusion-spheronization. optimization of the processing parameters and water content. Drug. Dev. Ind. Pharm., 2004, 30, 481-90.
18. Woodruff, C.W.; Nuessle, N.O. Effect of processing variables on particles obtained by extrusion-spheronization processing. J. Pharm. Sci., 1972, 61, 787-90.
19. Elbers, J.A.C.; Bakkenes, H.W; Fokkens, J.G. Effect of amount and composition of granulation liquid on mixing, extrusion and spheronization. Drug Dev. Ind. Pharm., 1992, 18, 501-17.
20. Ku, C.C.; Joshi, Y.M.; Bergum, J.S.; Jain, N.B. Bead manufacture by extrusion/spheronization- A statistical design for process optimization. Drug Dev. Ind. Pharm., 1993, 19, 1505-19.
21. Baert, L.; Remon, J. P. Influence of amount of granulation liquid on the drug-release rate from pellets made by extrusion spheronization. Int. J. Pharm., 1993, 95, 135-41.
22. Hicks, D.C.; Freese, H.L. Extrusion and spheronizing equipment. In Pharmaceutical pelletization technology. Marcel Dekker Inc.. New York and Basel., 1989, pp. 71.
23. Harrison, P.J.; Newton, J.M.; Rowe, R.C. The characterization of wet powder masses suitable for extrusion/spheronization. J. Pharm. Pharmacol., 1985a, 37, 686-91.
24. Fielden, K.E.; Newton, J.M.; Rowe, R.C. The influence of lactose particle size on spheronization of extrudate processed by a ram extruder. Int. J. Pharm., 1992a, 81, 205-12.
25. Nakahara, N. Method and apparatus for making spherical granules. US Patent 3277520, 1964.
26. Conine, J.W.; Hadley, H.R. Preparation of small, solid pharmaceutical spheres. Drug. Cosmet. Ind., 1970, 106, 38-41.
27. Rowe, R.C. Spheronization. A novel pill making pocess. Pharm. Int., 1985, 6, 119.
28. West, A.J.; Rowe, R.C. Polymeric coatings for pharmaceutical dosage forms. Manuf. Chem., 1988, 59, 79.
29. Gamlen, M.J. Pellet manufacture for controlled release. Manuf. Chem., 1985, 56, 55.
30. Hasznos, L.; Langer, I.; Gyarmathy, M. Some factors influencing pellet characteristics made by an extrusion/ spheronisation process. I. Effects on characteristics and moisture content decrease of pellets. Drug. Dev. Ind. Pharm., 1992, 18, 409-15.
31. Hellen, L.; Ritala, M.; Yliruusi, J.; Palmroos, P; Kristof-fersson, E. Process variables of the radial screen extruder. Part II. Size and distribution of pellets. Pharm. Tech. Int. Biophys., 1992, 4, 50-7.
32. Wan, L.S.C.; Heng, P.W.S.; Liew, C.V. Spheronization conditions on spheroid shape and size. Int. J. Pharm., 1993, 96, 59-65.
33. Souto, C.; Rodriguez, A.; Parajes, S.; Martinez-pacheco, R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusionspheronization. Eur. J. pharm. Biopharm., 2005, 61, 94-9.
34. Lian-Dong, H.; Yang, L.; Xing, T.; Qian, Z. Preparation and in vitro/in vivo evaluation of sustained- release metformin hydrochloride pellets. Eur. J. Pharm. Biopharm., 2006, 64, 185-92.
35. Thommes, M.; Kleinebudde, P. Use of κ-carrageenan as alternative pelletization aid to microcrystalline cellulose in extrusion/ spheronisation, I. influence of type and fraction of filler. Eur. J. Pharm. Biopharm., 2006, 63, 59-67.
36. Bataille, B.; Ligarski, K.; Jacob, M; Thomas, C.; Duru, C. Study of the influence of spheronization and drying conditions on the physico-mechanical properties of neutral spheroids containing Acivel PH 101 and lactose. Drug Dev. Ind. Pharm., 1993, 19, 653-60.
37. Huyghebaert, N.; Snoeck, V.; Vermeire, A.; Cox, E.; Goddeeris, M.B.; Remon, P.J. Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections. Eur. J. Pharm. Biopharm., 2005, 59, 273-81.
38. Husson, I.; Leclerc, B.; Spenlehauer, G.; Veillard, M.; Puisieux, F.; Couarraze, G. Influence of size polydispersity on drug release from coated pellets. Int. J. Pharm., 1992, 86, 113-21.
39. Fielden, K.E.; Newton, J.M.; Rowe, R.C. The influence of moisture content on spheronization of extrudate processed by ram extruder. Int. J. Pharm., 1993, 97, 79-86.
40. Kleinebudde, P. Application of low substituted hydroxypropyl cellulose (L-HPC) in the production of pellets using extrusion/ spheronization. Int. J. Pharm., 1993, 96, 119-28.
41. Harrison, P.J; Newton, J.M.; Rowe, R.C. The application of capillary rheometry to the extrusion of wet powder masses Int. J. Pharm., 1987, 35, 235-42.
42. Baert, L; Fanara, D; De Baets, P.; Remon, J.P. Instrumentation of a gravity feed extruder and the influence of the composition of binary and ternary mixtures on the extrusion forces. J. Pharm. Pharmacol., 1991, 43, 745- 9.
43. Flament, M.P; Dupont, G.; Leterme, P; Farah, N; Gayot, A. Development of 400 ?m pellets by extrusion-spheronization. Application with Gelucire 50/02 to produce a sprinkle form. Drug Dev. Ind. Pharm., 2004, 30, 43-51.
44. Millili, G.P.; Schwartz, J.B. The strength of microcrystalline cellulose pellets. The effect of granulating with water/ethanol mixtures. Drug Dev. Ind. Pharm., 1990, 16, 1411-26.
45. Kim, C.; Yoon, Y. The preparation of ascorbic acid pellets using the wet pelletization process in liquid media. Drug Dev. Ind. Pharm., 1991, 17, 581-7.
46. Steckel, H.; Mindermann-Nogly, F. Production of chitosan pellets by extrusion spheronization. Eur. J. Pharm. Biopharm., 2004, 57, 107-13.
47. Chatlapalli, R.; Rehears, B.D. Rheological characterization of diltiazem HCl/cellulose wet masses using a mixer torque rheometer. Int. J. Pharm., 1998, 161, 47-59.
48. Robinson, R.L.; Hollenbeck, R.G. Manufacture of spherical acetaminophen pellets. comparison of rotary processing with multiple-step extrusion and spheronization. Pharm. Technol. Pharm. Tech., 1991, 15, 48-56.
49. Hileman, G.A.; Goskonda, S.R.; Spalitto, A.; Upadrashta, S.M. A factorial approach to high dose product development by an extrusion spheronization process. Drug Dev. Ind. Pharm., 1993, 19, 483-91.
50. Chariot, M.; Frances, J.; Lewis, G.A.; Mathieu, D.; Phan Tan Luu, R.; Stevens, H.N.E. A factorial approach to process variables of extrusion/ spheronization of wet powder masses. Drug. Dev. Ind. Pharm., 1987, 13, 1639-49.
51. Bianchini, R.; Vecchio, C. Oral controlled release optimization of pellets prepared by extrusion-spheronization processing. Farmaco, 1989, 44, 645-54.
52. Chapman, S.R.; Rowe, R.C.; Harrison, P.J.; Newton, J.M. The influence of process variables on the density of granules produces by extrusion spheronization. Proc. 4th Cong. Int. Tech. Pharm., III. 1986, 9-14.
53. Harrison, P.J.; Newton, J.M.; Rowe, R.C. Flow defects in wet powder mass extrusion. J. Pharm. Pharmacol., 1985b, 37, 81-7.
54. Follonier, N.; Doelker, E.; Cole, E.T. Evaluation of hot melt extrusion as a new technique for the development of polymer base pellets for sustained release capsules containing high loadings of freely soluble drugs. Drug Dev. Ind. Pharm., 1994, 20, 1323-39.
55. Repka, M.A.; Gerding, T.G.; Repka, S.L.; McGinity, J.W. Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion. Drug Dev. Ind. Pharm., 1999, 25, 625-33.
56. Zhang, F.; McGnity, J.W. Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate). Drug Dev. Ind. Pharm., 2000, 26, 931-42.
57. Breitenbach, J. Melt extrusion. from process to drug delivery technology. Eur. J. Pharm. Biopharm., 2002, 54, 107-17.
58. Chung, C.I. Process Theory and practice In Extrusion of Polymers., ed.; Hanser. New York, 2000, pp. 215-25.
59. Perdikoulias, J.; Dobbie, T. In Pharmaceutical extrusion technology (Drugs and the pharmaceutical sciences) Marcel Dekker. New York, Vol. 2003, 133, pp. 471.
60. Crowley, M.C.; Schroeder, B.; Fredersdorf, A.; Obara, S.; Talarico, M.; Kucera, S. McGinity, J.W. A review of co-processed directly compressible excipients. Int. J. Pharm., 2004, 269, 509-22.
61. Sato, H.; Miyagawa, Y.; Okabe, T.; Miyajima, M.; Sunada, H. J. Pharm. Sci., 1997, 86, 929-36.
62. Repka, M.A.; Gerding, T.G.; Repka, S.L.; McGinity, J.W. Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof, US Patent 6375963, 2002.
63. Zhang, F.; McGnity, J.W. Properties of sustained-release tablets prepared by hot melt extrusion. Drug Dev. Technol., 1999, 4, 241-53.
64. Follonier, N.; Doelker, E.; Cole, E.T. Various ways of modulating the release of diltiazem hydrochloride from hot-melt extruded sustained release pellets prepared using polymeric materials J. Control. Release, 1995, 36, 243-50.
65. Wu, C.; McGinity, J.W. Non-traditional plasticization of polymeric films. Int. J. Pharm., 1999, 177, 15-7.
66. Cheboyina, S.; Wyandt, C.M. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique. I. Formulation and process variables affecting pellet characteristics. Int. J. Pharm., 2008, 359, 158-66.
67. Cheboyina, S.; Wyandt, C.M. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique. II. In vitro drug release studies and release mechanisms. Int. J. Pharm., 2008, 359, 167-73.
68. Buchmuller, J.; Weyermanns, G. Device for the controlled freezing of viscous liquids. US patent 4829783, 1989.
69. Weyermanns, G. Freezing and pelletizing process and device for pourable and flowing materials. US patent, 5694777, 1997.
70. Schvester. Preparing matrix pellets International publication number WO 01/68231, 2001.
71. Cheboyina, S.; O'Haver, J.; Wyandt, C.M. mathematical model to predict the size of the pellets formed in freeze pelletization techniques. Parameters affecting pellet size J. Pharm. Sci., 2006, 95, 167-80.
72. Wiwattanapatapee, R.; Pengnoo, A.; Kanjanamaneesathian, M.; Matchavanich, L.; Janatharangsri, A. Floating pellets containing bacterial antagonist for control sheath blight of rice. formulations, viability and bacterial release studies. J. Control. Release, 2004, 95, 455-61.
73. Baert, L.; Fanara, D.; Remon, J.P.; Massart, D. Correlation of extrusion forces, raw materials and sphere characteristics J. Pharm. Pharmacol., 1992a, 44, 676-83.
74. Frenning, G.; Tunon, A.; Alderborn, G. Modelling of drug release from coated granular pellets. J. Control. Release., 2003, 92, 113-8.
75. Bornhoft, M.; Thomames, M.; Kleinibudde, P. Preliminary assessment of carrageenan as excipient for extrusion/spheronization. Eur. J. Pharm. Biopharm., 2005, 59, 127-31.
76. Chapman, S.R.; Rowe, R.C.; Newton, J.M. Characterization of the sphericity of particles by the one plane critical stability. J. Pharm. Pharmacol., 1988, 40, 503-5.
77. Newton, J.M.; Chow, A.K.; Jeewa, K.B. The effect of excipient source on spherical granules made by extrusion/spheronization Pharm. Tech. Int. Biophys., 1992, 4, 52-9.
78. Lopez, M.E.V.; Reyes, L.N.; Anguiano S.; Otero-Espinar, F.J.; Méndez, J.B.. Formulation of triamcinolone acetonide pellets suitable for coating and colon targeting. Int. J. Pharm., 1999, 179, 229-35.
79. Huyghebaert, N.; Vermeire, A.; Neirynck, S.; Steidler, L.; Remaunt, E.; Remon, J.P. Evaluation of extrusion/spheronisation, layering and compaction for the preparation of an oral, multi-particulate formulation of viable, hIL-10 producing Lactococcus lactis. Eur. J. Pharm. Biopharm., 2005, 59, 9-15.
80. Siepmann, F.; Seipmann, J.; Walther, M.; Macrae, R.J.; Bodmeier, R. Blends of aqueous polymer dispersions used for pellet coating. Importance of the particle size J. Control. Release., 2005, 105, 226-39.
81. Eerikainen, S.; Lindqvist, A.S. The behaviour of various fillers in spheronized uncoated and film-coated granules containing slightly water-soluble indomethacin. Int. J. Pharm., 1991, 75, 181-92.
82. Prieto, S. A.; Mendez, J. B.; Espinar, F.J.O. Starch-dextrin mixtures as base excipients for extrusion-spheronization pellets. Eur. J. Pharm. Biopharm., 2005, 59, 511-21.
83. Baert, L.; Remon, J. P.; EIbers, J. A. C.; Van Bommel, E. M. G. Comparison between gravity feed extruder and twin screw extruder. Int. J. Pharm., 1993b, 99, 7-12.
84. Mesiha, M.S.; Valles, J. A screening study of lubricants in wet powder masses suitable for extrusion-spheronization Drug Dev. Ind. Pharm., 1993, 19, 943-59.
85. Noche, C.R.; Huct de Baroche, B.; Brossard, C.; Horvath, S.; Cuine, A. Optimizing the manufacturing process for controlled release pellets. Pharm. Technol., 1994, 39-42, 44-6.
86. Salako, M.; Podczeck, F.; Newton, J.M. Investigation into the deformity and tensile strength of pellets. Int. J. Pharm., 1998, 168, 49-57.
87. Wang, P.T.; Zaidi, M.A. Thermomechanical deformation of powder based porous aluminium. Part I. Evolution of pore structure. Powder Technol., 1991, 66, 9-19.
88. Costa, F.O.; Sousa, J.J.S.; Pais, A.A.C.C. Formosinho, S.J. Comparison of dissolution profiles of ibuprofen pellets. J. Control. Release, 2003, 89, 199-212.
89. Dashevsky, A.; Kolter, K.; Bodmeir, R. pH-independent release of a basic drug from pellets coated with the extended release polymer dispersion Kollicoat® SR 30 D and the enteric polymer dispersion Kollicoat® MAE 30 DP. Eur. J. Pharm. Biopharm., 2004, 58, 45-9.